Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation

Details for Australian Patent Application No. 2002319693 (hide)

International Classifications

Event Publications

16 January 2003 Complete Application Filed

Priority application(s): 60/308,500 27.07.01 US; 60/373,048 16.04.02 US

29 May 2003 Application Open to Public Inspection

Published as AU-B-2002319693

3 April 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

19 June 2008 Section 223 Application Received

Bayer Pharmaceuticals Corporation An application to extend the time from 25 Jul 2007 to 25 Apr 2008 in which to pay a continuation fee has been filed . Address for service in Australia - Davies Collison Cave 255 Elizabeth Street Sydney NSW 2000

7 August 2008 Section 223 Application Allowed

Bayer Pharmaceuticals Corporation The time in which to pay a continuation fee has been extended to 25 Apr 2008. Address for service in Australia - Davies Collison Cave 255 Elizabeth Street Sydney NSW 2000

7 August 2008 Application Accepted

Published as AU-B-2002319693

4 December 2008 Standard Patent Sealed

8 January 2009 Licence Registered

Bayer Pharmaceuticals Corporation ( Dara BioSciences Inc. )

15 April 2010 Assignment Registered

Bayer Pharmaceuticals Corporation The patent has been assigned to Bayer HealthCare LLC

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.